The Trump administration's effort to impose new requirements on Novavax's COVID-19 vaccine -- the nation's only traditional ...

There’s new uncertainty about updated COVID-19 shots this fall after the Trump administration’s handling of a shot from ...

The US Food and Drug Administration has discussed with vaccine-maker Novavax the need for an additional trial of its Covid-19 ...

Like all Covid vaccine manufacturers, Novavax updates the strain its vaccine targets annually — on instructions from the FDA. The regulatory agency has not viewed such tweaks — needed because ...

The President Donald Trump administration's request for Novavax Inc. to conduct new clinical trials for its COVID-19 vaccine has created uncertainty across the vaccine industry, potentially affecting ...

Novavax’s COVID-19 vaccine could soon receive full approval from the United States Food and Drug Administration.

Full approval from the FDA means a product can stay on the market even after a health emergency ends. HealthDay News — Novavax’s COVID-19 vaccine could soon receive full approval from the US ...

CHICAGO, April 24 (Reuters) - Thousands of Americans campaigning for the Novavax (NVAX.O), opens new tab COVID-19 booster got some good news this week: the FDA signaled it might still win approval ...

The US Food and Drug Administration has discussed with vaccine-maker Novavax the need for an additional trial of its Covid-19 vaccine ... to speak on behalf of the FDA. Novavax had anticipated ...

But with FDA action, it would be the third vaccine against COVID-19 to receive full FDA approval, which could provide additional reassurance to people seeking the shot.The missed deadline came at ...

Products that receive emergency authorization can be removed by FDA after there is no longer a health emergency. All the COVID-19 vaccines used in the U.S. train the body to fight the coronavirus ...